Empagliflozin on Patients With Preserved Heart Failure
Status:
COMPLETED
Trial end date:
2025-07-30
Target enrollment:
Participant gender:
Summary
The proposed research in this application will investigate the effect of empagliflozin on cardiac remodeling in patients with heart failure with preserved ejection fraction.